West Virginia Attorney General Patrick Morrisey said the state will receive more than $153,000 in a national settlement with a prescription drug manufacturer.
Morrisey says in a news release last month that every state and the District of Columbia are participating in the $13.5 million settlement with Boehringer Ingelheim Pharmaceuticals Inc.
The settlement resolves allegations that the company misrepresented the effectiveness of four drugs in treating or managing certain health conditions, including heart attacks, congestive heart failure and chronic obstructive pulmonary disease. The drugs are Micardis, Aggrenox, Atrovent and Combivent.
Topics Virginia
Was this article valuable?
Here are more articles you may enjoy.
Powerful El Niño Nears Record Strength, US Forecasters Say 
25 Years Later: IJ’s Past and Continued Coverage of the Insurance Impact of 9/11 
OpenAI Top Scientist Urges ‘Extreme Caution’ With Pace of AI 
Aon Acquires USI Insurance From KKR in $17 Billion Deal Targeting Middle Market 
